Association of CT dinucleotide repeat polymorphism in the 5′-flanking region of the guanylyl cyclase (GC)-A gene with essential hypertension in the Japanese

Hypertension Research

Volumn 31, Issue 1, 2008, Pages 89-96

  Usami, Satoru ^a   Kishimoto, Ichiro ^b   Saito, Yoshihiko ^c   Harada, Masaki ^a   Kuwahara, Koichiro ^a   Nakagawa, Yasuaki ^a   Nakanishi, Michio ^a   Yasuno, Shinji ^a   Kangawa, Kenji ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Guanyl cyclase (GC) A; Hypertension; Polymorphism; Transcriptional activity

Indexed keywords

ADENINE; CYTOSINE; GUANINE; GUANYLATE CYCLASE; LUCIFERASE; NATRIURETIC PEPTIDE RECEPTOR A; THYMINE;

ADULT; AGED; AORTA MEDIA; ARTICLE; CELL CULTURE; CODON; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA FLANKING REGION; ESSENTIAL HYPERTENSION; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; SMOOTH MUSCLE FIBER;

5' FLANKING REGION; AGED; ALLELES; CELLS, CULTURED; DINUCLEOTIDE REPEATS; DNA; FEMALE; GENE FREQUENCY; GENES, REPORTER; GENOTYPE; GUANYLATE CYCLASE; HUMANS; HYPERTENSION; JAPAN; LUCIFERASES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PLASMIDS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 40149085389     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.89     Document Type: Article

References (22)

1. de Bold AJ: Atrial natriuretic factor: a hormone produced by the heart. Science 1985; 230: 767-770.
2. Kangawa K, Matsuo H: Purification and complete amino acid sequence of alpha-human atria] natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984; 118: 131-139.
3. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
4. Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens 1992; 10: 1111-1114.
5. Rosenzweig A, Seidman CE: Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 1991; 60: 229-255.
6. Garbers DL: Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 1992; 71: 1-4.
7. Bennet BD, Bennet GL, Vitangcol RV: Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. J Biol Chem 1991; 266: 23060-23067.
8. Lopez MJ, Garbers DL, Kuhn M: The guanylyl cyclase-deficient mouse defines differential pathways of natriuretic peptide signaling. J Biol Chem 1997; 272: 23064-23068.
9. Lopez MJ, Wong SK, Kishimoto I, et al: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic: peptide. Nature 1995; 378: 65-68.
10. Oliver PM, Fox JE, Kim R, et al: Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997; 94: 14730-14735.
11. Oliver PM, John SW, Purdy KE, et al: Natriuretic eptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci U S A 1998; 95: 2547-2551.
12. Takahashi Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse K: Organization of the human natriuretic peptide receptor A gene. Biochem Biophys Res Commun 1998; 246: 736-739.
13. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K: Functional deletion mutation of the 5′-flanking region of type A human natriuretic eptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 2000; 86: 841-845.
14. Nakayama T, Soma M, Takahashi Y, et al: Nucleotide sequence of the 5′-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. Am J Hypertens 1999; 12: 1144-1148.
15. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, Maeda N: Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet 2003; 112: 62-70.
16. Miyamoto Y, Saito Y, Kajiyama N, et al: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8.
17. Kajiyama N, Saito Y, Miyamoto Y, et al: Lack of association between T-786←C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 2000; 23; 561-565.
18. Nakao K, Sugawara A, Morii N, et al: Radioimmunoassay for alpha-human and rat atrial natriuretic polypeptide. Biochem Biophys Res Commun 1984; 124: 815-821.
19. Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
20. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M: Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with hypertension in Japanese. Clin Genet 1997; 51: 26-30.
21. Rubattu S, Bigatti G, Evangelista A, et al: Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48: 499-505.
22. Nishikimi T, Maeda N, Matsuoka H: The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006; 69: 318-328.